Uro-Vaxom® versus placebo for the prevention of recurrent symptomatic urinary tract infections in participants with chronic neurogenic bladder dysfunction: a randomised controlled feasibility study

Uro-Vaxom® versus placebo for the prevention of recurrent symptomatic urinary tract infections in participants with chronic neurogenic bladder dysfunction: a randomised controlled feasibility study

Abstract Background Patients with lower neurogenic bladder dysfunction are at an increased risk of suffering from recurrent urinary tract infections. Recurrent symptomatic urinary tract infection is occasionally treated with antibiotics as a prophylactic prevention strategy. This risks increasing th...

Full description

Bibliographic Details
Main Authors: Derick Wade, James Cooper, Fadel Derry, Julian Taylor
Format: Article
Language:English
Published: BMC 2019-04-01
Series:Trials
Subjects:
Symptomatic urinary tract infection
Escherichia coli
Prophylactic immunotherapy
Uro-Vaxom®
Lower neurogenic bladder dysfunction
Spinal cord injury
Online Access:http://link.springer.com/article/10.1186/s13063-019-3275-x

Internet

http://link.springer.com/article/10.1186/s13063-019-3275-x

Similar Items